Literature DB >> 9649227

T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.

W J King1, C J Brooks, R Holder, P Hughes, D Adu, C O Savage.   

Abstract

ANCA with specificity for myeloperoxidase (MPO) and proteinase 3 (PR3) are present in patients with systemic vasculitis. The aim of this work was to determine whether such patients have T cell responses to these antigens and whether these responses are related to disease activity. Peripheral blood lymphocytes from 45 patients and 19 controls were cultured with ANCA antigens and proliferation measured. The antigens used were heat-inactivated (HI) MPO, HI PR3, native (non-HI) PR3, HI whole alpha-granules, and 25 overlapping peptides covering the entire PR3 sequence. Significant responses to both whole PR3 preparations were seen from patient and control groups, and to the alpha-granules from the patient group. Patients responded at all stages of disease: active, remitting, treated or untreated. Only two patients responded significantly to MPO. Responses were significantly higher with the patient group than the control group to all four whole ANCA antigens. Responses to those PR3 peptides containing epitopes known to be recognized by ANCA were detected from one patient. Thus, these studies demonstrate that T cells from vasculitis patients can proliferate to PR3 and occasionally to associated ANCA antigens. Further, responses may persist even after disease remission has been achieved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649227      PMCID: PMC1904981          DOI: 10.1046/j.1365-2249.1998.00615.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseases.

Authors:  P Schollmeyer; W Grotz
Journal:  APMIS Suppl       Date:  1990

2.  An exact comparison between the efficiency of two- and three-cell-type clusters in mediating helper activity.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

Review 3.  Primary systemic vasculitis.

Authors:  C O Savage; L Harper; D Adu
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

4.  The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms.

Authors:  F J van der Woude; L A van Es; M R Daha
Journal:  Neth J Med       Date:  1990-04       Impact factor: 1.422

5.  Monoclonal-antibody therapy in systemic vasculitis.

Authors:  P W Mathieson; S P Cobbold; G Hale; M R Clark; D B Oliveira; C M Lockwood; H Waldmann
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

Review 6.  The mechanism of immunological paralysis.

Authors:  D W Dresser; N A Mitchison
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.

Authors:  C M Dayan; M Londei; A E Corcoran; B Grubeck-Loebenstein; R F James; B Rapoport; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects.

Authors:  R Liblau; E Tournier-Lasserve; J Maciazek; G Dumas; O Siffert; G Hashim; M A Bach
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

9.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Leukocyte analysis using monoclonal antibodies in human glomerulonephritis.

Authors:  D H Hooke; D C Gee; R C Atkins
Journal:  Kidney Int       Date:  1987-04       Impact factor: 10.612

View more
  16 in total

1.  Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis.

Authors:  C E Balding; A J Howie; A B Drake-Lee; C O Savage
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  ANCA patients have T cells responsive to complementary PR-3 antigen.

Authors:  Jiajin Yang; David J Bautz; Sofia Lionaki; Susan L Hogan; Hyunsook Chin; Roland M Tisch; John L Schmitz; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

5.  Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.

Authors:  Kouichi Hirayama; Takashi Ishizu; Homare Shimohata; Yasunori Miyamoto; Tomoko Kakita; Miho Nagai; Yujiro Ogawa; Shogo Fujita; Aki Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2009-10-07       Impact factor: 2.801

6.  Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.

Authors:  S Marinaki; I Neumann; A-I Kälsch; P Grimminger; A Breedijk; R Birck; W Schmitt; R Waldherr; B A Yard; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 7.  Cytokines: Names and Numbers You Should Care About.

Authors:  Stephen R Holdsworth; Poh-Yi Gan
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-04       Impact factor: 8.237

8.  In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG).

Authors:  Y M van der Geld; M G Huitema; C F Franssen; R van der Zee; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

9.  Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases.

Authors:  Marta Christensson; Erna Pettersson; Kjell Eneslätt; Birger Christensson; Johan Bratt; Solbritt Rantapää-Dahlqvist; Karl-Gösta Sundqvist
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

10.  Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?

Authors:  A-I Kälsch; M Soboletzki; W H Schmitt; F J van der Woude; A Hochhaus; B A Yard; R Birck
Journal:  Clin Exp Immunol       Date:  2008-01-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.